Standifer KM - Search Results

1

Opioid binding in giant toad and goldfish brain.

Brooks AI, Standifer KM, Cheng J, Ciszewska G, Pasternak GW. Brooks AI, et al. Among authors: standifer km. Receptor. 1994 Spring;4(1):55-62. Receptor. 1994. PMID: 8038707

2

Mapping of opioid receptors using antisense oligodeoxynucleotides: correlating their molecular biology and pharmacology.

Pasternak GW, Standifer KM. Pasternak GW, et al. Among authors: standifer km. Trends Pharmacol Sci. 1995 Oct;16(10):344-50. doi: 10.1016/s0165-6147(00)89068-9. Trends Pharmacol Sci. 1995. PMID: 7491712 Review.

3

Cloning and functional characterization through antisense mapping of a kappa 3-related opioid receptor.

Pan YX, Cheng J, Xu J, Rossi G, Jacobson E, Ryan-Moro J, Brooks AI, Dean GE, Standifer KM, Pasternak GW. Pan YX, et al. Among authors: standifer km. Mol Pharmacol. 1995 Jun;47(6):1180-8. Mol Pharmacol. 1995. PMID: 7603458

4

Demonstration of kappa 3-opioid receptors in the SH-SY5Y human neuroblastoma cell line.

Cheng J, Standifer KM, Tublin PR, Su W, Pasternak GW. Cheng J, et al. Among authors: standifer km. J Neurochem. 1995 Jul;65(1):170-5. doi: 10.1046/j.1471-4159.1995.65010170.x. J Neurochem. 1995. PMID: 7790858

5

Biochemical and pharmacological characterization of mu, delta and kappa 3 opioid receptors expressed in BE(2)-C neuroblastoma cells.

Standifer KM, Cheng J, Brooks AI, Honrado CP, Su W, Visconti LM, Biedler JL, Pasternak GW. Standifer KM, et al. J Pharmacol Exp Ther. 1994 Sep;270(3):1246-55. J Pharmacol Exp Ther. 1994. PMID: 7932177

6

Selective loss of delta opioid analgesia and binding by antisense oligodeoxynucleotides to a delta opioid receptor.

Standifer KM, Chien CC, Wahlestedt C, Brown GP, Pasternak GW. Standifer KM, et al. Neuron. 1994 Apr;12(4):805-10. doi: 10.1016/0896-6273(94)90333-6. Neuron. 1994. PMID: 8161452

7

Modulation of Mu1 opioid binding by magnesium: evidence for multiple receptor conformations.

Standifer KM, Clark JA, Pasternak GW. Standifer KM, et al. J Pharmacol Exp Ther. 1993 Jul;266(1):106-13. J Pharmacol Exp Ther. 1993. PMID: 8392546

8

Characterizing kappa3 opioid receptors with a selective monoclonal antibody.

Brooks AI, Standifer KM, Rossi GC, Mathis JP, Pasternak GW. Brooks AI, et al. Among authors: standifer km. Synapse. 1996 Mar;22(3):247-52. doi: 10.1002/(SICI)1098-2396(199603)22:3<247::AID-SYN7>3.0.CO;2-C. Synapse. 1996. PMID: 9132993

9

TIPP[psi], a highly selective delta ligand.

Visconti LM, Standifer KM, Schiller PW, Pasternak GW. Visconti LM, et al. Among authors: standifer km. Neurosci Lett. 1994 Nov 7;181(1-2):47-9. doi: 10.1016/0304-3940(94)90557-6. Neurosci Lett. 1994. PMID: 7898768

10

Affinity labeling of mu and kappa receptors with naloxone benzoylhydrazone.

Standifer KM, Murthy LR, Kinouchi K, Steele L, Pasternak GW. Standifer KM, et al. Mol Pharmacol. 1991 Mar;39(3):290-8. Mol Pharmacol. 1991. PMID: 1848652

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

62 results

Search Page